We are live on
!
Find out more
Medifast
MED
MED
236 hedge funds and large institutions have $892M invested in Medifast in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 88 increasing their positions, 80 reducing their positions, and 62 closing their positions.
New
Increased
Maintained
Reduced
Closed
10% more repeat investments, than reductions
Existing positions increased: 88 | Existing positions reduced: 80
4.99% less ownership
Funds ownership: 93.78% → 88.79% (-5%)
12% less funds holding
Funds holding: 267 → 236 (-31)
16% less capital invested
Capital invested by funds: $1.06B → $892M (-$169M)
50% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 62
64% less call options, than puts
Call options by funds: $10.9M | Put options by funds: $30.3M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
236
Holders Change
-31
Holders Change %
-11.61%
% of All Funds
3.71%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
31
Increased
88
Reduced
80
Closed
62
Calls
$10.9M
Puts
$30.3M
Net Calls
-$19.3M
Net Calls Change
-$11.3M
Top Buyers
| 1 |
Man Group
London,
United Kingdom
|
+$13.4M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$8.5M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$5.43M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$4.71M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.65M |
